An evaluation of a circulating tumor cell-based Device (TriNetraTM-Breast) for breast cancer screening in women aged 40 and above. – UROP Symposium

An evaluation of a circulating tumor cell-based Device (TriNetraTM-Breast) for breast cancer screening in women aged 40 and above.

Sara Garcia

Pronouns:

Research Mentor(s): Ulka Vaishampayan
Research Mentor School/College/Department: Internal Medicine, Hem/Oncology / Medicine
Program:
Authors:
Session: Session 2: 10:00 am – 10:50 am
Poster: 60

Abstract

While progress has been made in the cancer screening process, many women still face challenges in their efforts to be diagnosed early with breast cancer. Mammograms are uncomfortable and involve radiation exposure and, as a result, many women put off getting this test, and do not receive screening for early detection of breast cancer. Mammograms are not available in rural and underserved areas and are not easily accessible. Without screening, there is a risk of not finding cancer until it is already in its later stages, and the chance of cure is reduced.

Biomedical Sciences, Interdisciplinary

lsa logoum logo